Long-term outcome prediction for chronic thromboembolic pulmonary hypertension after pulmonary endarterectomy.

ABSTRACT:

Background

The definitive treatment for chronic thromboembolic pulmonary hypertension (CTEPH) is pulmonary endarterectomy (PEA), which has good long-term outcomes. However, after surgery, a quarter of the patients still have residual pulmonary hypertension (RPH). In pulmonary hemodynamics, there are no unified criteria for RPH, even though the level may affect long-term survival.

Methods

Between March 1997 and December 2021, 253 CTEPH patients were treated at our center with PEA. Patients were evaluated retrospectively and classified into early (1997-2014) and late (2015-2021) groups. The clinical characteristics and perioperative outcomes of the two groups were compared, and risk factor analysis for RPH and long-term survival for all cases was performed.

Results

Ther

SUBMITTER: Song W 

PROVIDER: S-EPMC9748755 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature